Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingrui Huang

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Bioconjugate Chemistry|March 23, 2016
Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) ConjugateQingrui Huang, Weili Yu, Tao Hu
Emerging Microbes & Infections|September 15, 2022
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodiesQingrui Huang, Xiaonan Han, Jinghua Yan
Cell Host & Microbe|November 14, 2024
mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunizationXiaonan Han, Qingrui Huang, Jinghua Yan
Journal of Genetics and Genomics = Yi Chuan Xue Bao|May 19, 2021
COVID-19 mRNA vaccinesQingrui Huang, Jiawei Zeng, Jinghua Yan
International Journal of Biological Macromolecules|January 5, 2025
A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimineYu Tian, Lijia Hu, Qingrui Huang, et al.
Frontiers in Immunology|September 14, 2023
Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarificationYuping Zheng, Qingrui Huang, Yanfeng Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2013
PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccineQingrui Huang, Dongxia Li, Aijun Kang, et al.
Scientific Reports|October 12, 2024
ELISA genotyping of hepatitis B virus in China with antibodies specific for genotypes B and CYumin Li, Li Wang, Huanyi Cheng, et al.
Ebiomedicine|October 7, 2022
A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion coreRui Shi, Jiawei Zeng, Ling Xu, et al.
Emerging Microbes & Infections|April 18, 2023
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challengeJiawei Zeng, Yao Li, Linrui Jiang, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Bioconjugate Chemistry|March 23, 2016
Potent Antigen-Adjuvant Delivery System by Conjugation of Mycobacterium tuberculosis Ag85B-HspX Fusion Protein with Arabinogalactan-Poly(I:C) ConjugateQingrui Huang, Weili Yu, Tao Hu
Emerging Microbes & Infections|September 15, 2022
Structure-based neutralizing mechanisms for SARS-CoV-2 antibodiesQingrui Huang, Xiaonan Han, Jinghua Yan
Cell Host & Microbe|November 14, 2024
mRNA vaccines: A promising platform for safer, more effective next-generation Orthopoxvirus immunizationXiaonan Han, Qingrui Huang, Jinghua Yan
Journal of Genetics and Genomics = Yi Chuan Xue Bao|May 19, 2021
COVID-19 mRNA vaccinesQingrui Huang, Jiawei Zeng, Jinghua Yan
International Journal of Biological Macromolecules|January 5, 2025
A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimineYu Tian, Lijia Hu, Qingrui Huang, et al.
Frontiers in Immunology|September 14, 2023
Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarificationYuping Zheng, Qingrui Huang, Yanfeng Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 21, 2013
PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccineQingrui Huang, Dongxia Li, Aijun Kang, et al.
Scientific Reports|October 12, 2024
ELISA genotyping of hepatitis B virus in China with antibodies specific for genotypes B and CYumin Li, Li Wang, Huanyi Cheng, et al.
Ebiomedicine|October 7, 2022
A combination vaccine against SARS-CoV-2 and H1N1 influenza based on receptor binding domain trimerized by six-helix bundle fusion coreRui Shi, Jiawei Zeng, Ling Xu, et al.
Emerging Microbes & Infections|April 18, 2023
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challengeJiawei Zeng, Yao Li, Linrui Jiang, et al.
Pageof 2